Jouneau, S;
Dres, M;
Guerder, A;
Bele, N;
Bellocq, A;
Bernady, A;
Berne, G;
Bourdin, A;
Brinchault, G;
Burgel, P. R;
Carlier, N;
Chabot, F;
Chavaillon, J. M;
Cittee, J;
Claessens, Y. E;
Delclaux, B;
Deslée, G;
Ferré, A;
Gacouin, A;
Girault, C;
Ghasarossian, C;
Gouilly, P;
Gut-Gobert, C;
Gonzalez-Bermejo, J;
Jebrak, G;
Le Guillou, F;
Léveiller, G;
Lorenzo, A;
Mal, H;
Molinari, N;
Morel, H;
Morel, V;
Noel, F;
Pégliasco, H;
Perotin, J. M;
Piquet, J;
Pontier, S;
Rabbat, A;
Revest, M;
Reychler, G;
Stelianides, S;
Surpas, P;
Tattevin, P;
Roche, N.
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of ...
BACKGROUND: Wet or productive cough is common in children with chronic cough. We formulated recommendations based on systematic reviews related to the management of chronic wet cough in children (aged ≤ 14 years) based on two key questions: (1) how effective are antibiotics in improving the resolution ...
INTRODUCTION: This guideline establishes clinical practice recommendations for the diagnosis of obstructive sleep apnea (OSA) in adults and is intended for use in conjunction with other American Academy of Sleep Medicine (AASM) guidelines on the evaluation and treatment of sleep-disordered breathing in a...
Rhodes, A;
Evans, L. E;
Alhazzani, W;
Levy, M. M;
Antonelli, M;
Ferrer, R;
Kumar, A;
Sevransky, J. E;
Sprung, C. L;
Nunnally, M. E;
Rochwerg, B;
Rubenfeld, G. D;
Angus, D. C;
Annane, D;
Beale, R. J;
Bellinghan, G. J;
Bernard, G. R;
Chiche, J. D;
Coopersmith, C;
De Backer, D. P;
French, C. J;
Fujishima, S;
Gerlach, H;
Hidalgo, J. L;
Hollenberg, S. M;
Jones, A. E;
Karnad, D. R;
Kleinpell, R. M;
Koh, Y;
Lisboa, T. C;
Machado, F. R;
Marini, J. J;
Marshall, J. C;
Mazuski, J. E;
McIntyre, L. A;
McLean, A. S;
Mehta, S;
Moreno, R. P;
Myburgh, J;
Navalesi, P;
Nishida, O;
Osborn, T. M;
Perner, A;
Plunkett, C. M;
Ranieri, M;
Schorr, C. A;
Seckel, M. A;
Seymour, C. W;
Shieh, L;
Shukri, K. A;
Simpson, S. Q;
Singer, M;
Thompson, BT;
Townsend, SR;
Van der Poll, T;
Vincent, J. L;
Wiersinga, W. J;
Zimmerman, J. L;
Dellinger, R. P.
OBJECTIVE: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012". DESIGN: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for t...
Enfermedad Crónica/tratamiento farmacológico,
Sepsis/tratamiento farmacológico,
Choque Séptico/tratamiento farmacológico,
Antibacterianos/administración & dosificación,
Vasoconstrictores/uso terapéutico,
Calcitonina/uso terapéutico,
Fluidoterapia/métodos,
Evaluación Nutricional,
Planificación de Atención al Paciente,
Terapia de Reemplazo Renal,
Respiración Artificial
Lewinsohn, DM;
Leonard, MK;
LoBue, PA;
Cohn, DL;
Daley, CL;
Desmond, E;
Keane, J;
Lewinsohn, DA;
Loeffler, AM;
Mazurek, GH;
O'Brien, RJ;
Pai, M;
Richeldi, L;
Salfinger, M;
Shinnick, TM;
Sterling, TR;
Warshauer, DM;
Woods, GL.
BACKGROUND: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality...
Ouellette, DR;
Patel, S;
Girard, TD;
Morris, PE;
Schmidt, GA;
Truwit, JD;
Alhazzani, W;
Burns, SM;
Epstein, SK;
Esteban, A;
Fan, E;
Ferrer, M;
Fraser, GL;
Gong, MN;
Hough, CL;
Mehta, S;
Nanchal, R;
Pawlik, AJ;
Schweickert, WD;
Sessler, CN;
Strøm, T;
Kress, JP.
DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Schmidt, GA;
Girard, TD;
Kress, JP;
Morris, PE;
Ouellette, DR;
Alhazzani, W;
Burns, SM;
Epstein, SK;
Esteban, A;
Fan, E;
Ferrer, M;
Fraser, GL;
Gong, MN;
Hough, CL;
Mehta, S;
Nanchal, R;
Patel, S;
Pawlik, AJ;
Schweickert, WD;
Sessler, CN;
Strøm, T;
Wilson, KC;
Truwit, JD.
Mazuski, J. E;
Tessier, J. M;
May, A. K;
Sawyer, R. G;
Nadler, E. P;
Rosengart, M. R;
Chang, P. K;
O'Neill, P. J;
Mollen, K. P;
Huston, J. M;
Diaz, J. J. Jr.
BACKGROUND: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update the guideline every five years to ensure the timel...
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibacterianos/uso terapéutico,
Inhibidores de la Bomba de Protones/uso terapéutico,
Bismuto/uso terapéutico,
Algoritmos,
Técnica Delfos,
Quimioterapia Combinada,
Gastritis/complicaciones,
Infecciones por Helicobacter,
Helicobacter pylori,
Probióticos,
Inhibidores de la Bomba de Protones,
Recurrencia,
Terapia Recuperativa,
Neoplasias Gástricas,
Úlcera Gástrica,
Insuficiencia del Tratamiento,
Gastritis/tratamiento farmacológico,
Infecciones por Helicobacter/tratamiento farmacológico,
Helicobacter pylori/efectos de los fármacos
Ye, ZK;
Chen, YL;
Chen, K;
Zhang, XL;
Du, GH;
He, B;
Li, DK;
Liu, YN;
Yang, KH;
Zhang, YY;
Zhai, SD.
BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...
